USD 1.57 billion
Fetal Bovine Serum Market Size, Share, Growth Analysis, By End-user(Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users), By Application(Biopharmaceutical Production, Monoclonal antibodies, Vaccines production, Other therapeutic proteins), By Type(Serum-free Media, CHO Media, HEK 293 Media, BHK Media), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2208 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
108
|Figures:
76
Fetal Bovine Serum Market Insights
Fetal Bovine Serum Market size was valued at USD 1.79 Billion in 2023 and is poised to grow from USD 2.04 Billion in 2024 to USD 5.88 Billion by 2032, growing at a CAGR of 14.1% during the forecast period (2025-2032).
Growing investments in cell research and biopharmaceutical research are projected to primarily drive up the demand for fetal bovine serum over the coming years. Advancements in cell culture technologies and rising demand for regenerative medicine are also expected to bolster fetal bovine serum market growth in the future. Rising incidence of chronic diseases and growing demand for cell therapies for their treatment are also expected to create new opportunities for fetal bovine serum companies in the long run. On the contrary, supply chain constraints, availability of alternatives, and variability in batches are some restraints that are slated to impede the adoption of fetal bovine serum in the future. Ethical concerns about animal testing are estimated to emerge as a key constraint for fetal bovine serum companies going forward.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Pharmaceutical & Biotechnology Companies
Fastest Growth
Contract & Academic Research Organizations
Growth Rate
14.1% CAGR
Global Fetal Bovine Serum Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Fetal Bovine Serum Market Segmental Analysis
The global fetal bovine serum market is segmented on the basis of end-user, application, and region. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, contract & academic research organizations. By application, the market is segmented into drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by End User
Pharmaceutical and biotechnology companies are projected to be the largest end users of fetal bovine serum around the world. Growing investments in cell research and rising use of fetal bovine serum in drug discovery and development process are expected to aid the dominance of this segment going forward. High emphasis on stem cell and regenerative medicine research is also expected to create new opportunities for fetal bovine serum companies focusing on this segment in the future. Pharmaceutical and biotechnology companies are expected to maintain their high fetal bovine serum market share across the forecast period owing to high demand for pharmaceuticals and biopharmaceuticals.
Meanwhile, the demand for fetal bovine serum in contract research organizations (CROs) is forecasted to rise at an impressive pace in the future. Growing popularity of outsourcing research and development in healthcare is projected to make this segment highly opportune in the long run. Rising healthcare research costs and increasing emphasis on improving efficiency in healthcare R&D process are also expected to promote the demand for fetal bovine serum in CROs over the coming years. The Asia Pacific region is expected to be highly opportune for fetal bovine serum providers targeting this segment owing to the presence of multiple CROs in this region.
Analysis by Application
Vaccine production is forecasted to account for a major chunk of the global fetal bovine serum market share in the future. Due to fetal bovine serum being rich in growth factors and nutrients it is extensively used in the production of vaccines as it promotes healthy cell growth and better proliferation. Rapidly increasing incidence of chronic and infectious diseases around the world and growing need for vaccines for the same are helping this segment lead the global fetal bovine serum demand outlook. The COVID-19 pandemic is a testament to how important vaccines development and production is when it comes to global diseases management.
On the other hand, the demand for fetal bovine serum for in-vitro fertilization is expected to increase at a notable CAGR over the coming years. The surging popularity of in-vitro fertilization and its increasing adoption around the world are creating new opportunities for fetal bovine serum suppliers going forward. Fetal bovine serum is capable of providing essential nutrients, hormones, and growth factors for healthy embryo development thereby making it a key element in in-vitro fertilization applications. Fetal bovine serum is mostly used in combination with human serum albumin to improve the quality of embryos.
Global Fetal Bovine Serum Market By Application
To get detailed analysis on other segments, Request For Free Sample Report
Fetal Bovine Serum Market Regional Insights
North America is forecasted to account for a high fetal bovine serum market share on a global level. Rising healthcare research and development activity, growing emphasis on improving biopharmaceutical production, and presence of multiple pharmaceutical companies are key factors allowing this region to maintain its dominant stance. The United States is slated to spearhead revenue generation in North America followed by Canada over the coming years. Availability of supportive government funding for medical research and rising investments in stem cell and regenerative medicine research are also slated to create new opportunities for fetal bovine serum providers in this region.
The demand for fetal bovine serum in the Asia Pacific region is slated to increase at an impressive pace across the study period. Growing investments in medical R&D and the presence of key pharmaceutical companies are creating new opportunities for fetal bovine serum suppliers. Rising awareness regarding benefits of cell therapies and the subsequent increase in their demand for treatment of chronic diseases is also expected to bolster the fetal bovine serum market forecast for the Asia-Pacific region through 2031 and beyond. India, Japan, and China are estimated to emerge as leading markets in this region owing to the presence of leading contract research organizations in these countries.
Global Fetal Bovine Serum Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Fetal Bovine Serum Market Dynamics
Fetal Bovine Serum Market Drivers
Rising Biopharmaceutical R&D Activity
- Surging use of monoclonal antibodies, vaccines, and cell therapies for the treatment of various diseases has resulted in high demand for biopharmaceutical research around the world. Fetal bovine serum is a key supplement in cell culture media required for biopharmaceutical production thereby making this a key fetal bovine serum market growth driver.
High Investments in Stem Cell Research
- Growing demand for regenerative medicine and cell therapies have resulted in high investments in stem cell research around the world. Fetal bovine serum plays a crucial role in cultivation of different cell types in stem cell research thereby making it a vital component for any stem cell research project.
Fetal Bovine Serum Market Restraints
Ethical Concerns Regarding Animal Welfare
- The collection of fetal bovine serum involves the use of bovine fetuses, which raises ethical concerns among animal welfare organizations. A rising number of people taking objection to medical practices involving animals is adding to the ethical conundrum and thereby limiting the global fetal bovine serum market outlook going forward.
Batch Variability Creating Inconsistency
- Fetal bovine serum is a natural product and derived straight from natural sources, which results in variations that cannot be controlled. These variations can result in inconsistency and thereby negatively affect experimental reproducibility and product quality as well. Hence, this variability in different fetal bovine serum batches is slated to slow down market development potential in the future.
Request Free Customization of this report to help us to meet your business objectives.
Fetal Bovine Serum Market Competitive Landscape
Fetal bovine serum providers should focus on solving the ethical concerns surrounding the production of their product to maximize business scope. Targeting countries where investments in cell research are high is expected to offer better returns on investments for fetal bovine serum providers. Fetal bovine serum companies should also try to achieve consistency in different batches of fetal bovine serum to improve consistency of results.
Fetal Bovine Serum Market Top Player’s Company Profiles
- Merck KGaA (Germany)
- GE Healthcare (US)
- Atlanta Biologicals Inc. (US)
- Sigma-Aldrich Corporation (US)
- Rocky Mountain Biologicals (US)
- PAN-Biotech GmbH (Germany)
- Bovogen Biologicals Pty Ltd. (Australia)
- Biowest SAS (France)
- Biological Industries Israel Beit Haemek Ltd. (Israel)
- Corning Incorporated (US)
- Sera Laboratories International Ltd. (UK)
- Caisson Laboratories Inc. (US)
- Hyclone Laboratories Inc. (US)
- Lanzhou Minhai Biotechnology Co., Ltd. (China)
- Moregate BioTech (UK)
- Gemini Bio-Products (US)
- Lampire Biological Laboratories (US)
Fetal Bovine Serum Market Recent Developments
- In June 2024, Omeat, a leading lab-grown meat provider announced the launch of a new white paper detailing the performance of its fetal bovine serum alternative across various cell types. Plenty, the ethical alternative to fetal bovine serum was launched by Omeat last year.
- In December 2021, Thermo Fisher Scientific, a leading healthcare technology company announced the completion of the acquisition of PPD Inc. The acquisition was completed at a valuation of USD 17.4 billion to help Thermo Fisher bolster its stance in clinical research business.
Fetal Bovine Serum Key Market Trends
- Use in 3D Cell Culture: Investments in 3D cell culture are increasing rapidly around the world and this is expected to present new opportunities for fetal bovine serum providers in the future. Fetal bovine serum can play a vital role in maintaining stability of complex 3D cell culture systems over the coming years and boost revenue generation potential for market players.
- Integration with Advanced Bioprocessing Technologies: Fetal bovine serum companies can focus on exploring new application scope for their offerings through integration with novel bioprocessing technologies. Use of automated and scalable bioprocessing technologies to improve consistency of fetal bovine serum is expected to be a key fetal bovine serum market trend in the long run.
Fetal Bovine Serum Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, high investments in cell research and development, and increasing biopharmaceutical research activity are projected to bolster fetal bovine serum market outlook in the future. However, batch variability and ethical concerns regarding sourcing are estimated to hamper fetal bovine serum demand over the coming years. High medical research investments and the presence of leading biopharmaceutical companies allow North America to maintain a dominant share of the global fetal bovine serum industry. Fetal bovine serum companies should focus on integrating their offerings with advanced bioprocessing technologies and target 3D cell culture to maximize their business scope in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.57 billion |
| Market size value in 2031 | USD 5.15 billion |
| Growth Rate | 14.1% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Fetal Bovine Serum Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Fetal Bovine Serum Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Fetal Bovine Serum Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Fetal Bovine Serum Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Fetal Bovine Serum Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Fetal Bovine Serum Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
